bufalin and Cancer-Associated Pain

bufalin has been researched along with Cancer-Associated Pain in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fang, J; Ji, D; Liang, Z; Liu, G; Zhao, G	1

Other Studies

1 other study(ies) available for bufalin and Cancer-Associated Pain

Article	Year
Bufalin attenuates cancer-induced pain and bone destruction in a model of bone cancer. Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:12 Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Bone and Bones; Bone Neoplasms; Bufanolides; Cancer Pain; Hyperalgesia; Indoles; Male; Mice; Osteoprotegerin; Pain Measurement; RANK Ligand; Receptor, Cannabinoid, CB2	2017

Article

Year

Bufalin attenuates cancer-induced pain and bone destruction in a model of bone cancer.

Naunyn-Schmiedeberg's archives of pharmacology, 2017, Volume: 390, Issue:12

Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Behavior, Animal; Bone and Bones; Bone Neoplasms; Bufanolides; Cancer Pain; Hyperalgesia; Indoles; Male; Mice; Osteoprotegerin; Pain Measurement; RANK Ligand; Receptor, Cannabinoid, CB2

2017